Nomir Medical Announces New Scientific Findings on Treating Toenail Fungus with the NoveonTM Laser
3/28/2012 7:51:49 AM
BROOKLYN, N.Y.--(BUSINESS WIRE)--Nomir Medical Technologies, Inc., a leader in novel photobiology and laser therapies, announced today that new data from its landmark pivotal onychomycosis trial first published in the peer-reviewed Journal of the American Podiatric Medical Association (JAPMA) has once again been published in this prestigious journal. The new paper, which reports on a 270 day onychomycosis clinical trial, offers further scientific support for using the Noveon lasers as an effective therapeutic treatment.
comments powered by